Brazil: suspension of the distribution of more than 12 million Sinovac vaccines | They had been produced in a factory without the necessary permits

Brazilian health authorities suspend distribution of a lot more than 12 million vaccines against the Sinovac coronavirus. The doses in question they had been produced in a factory which had not been inspected or which had the necessary authorizations.

As announced by the National Health Surveillance Agency (Anvisa), responsible for approving vaccines, the withdrawn lots come from a factory “which had not been inspected or approved in the emergency use authorization” of the product, the agency said. Europa Press news.

“In these terms, vaccines packaged in a location not approved in the emergency use authorization are considered an unregulated product by Anvisa,” the agency detailed in a statement.

The affected lots, which include vaccines that have not yet been delivered to the country, represent more than 12 million doses of CoronaVac, the first compound to be approved for emergency use in Brazil with the AstraZeneca vaccine.

In the declaration, Anvisa clarified that she had not found any assessment of the plant’s quality standards by other health organizations..

The agency assured that will devote this period to evaluating the standards of good practice of the plant in question, but also the possible impact on the population that has already been vaccinated with batches from the same location.

In Brazil, the second country in the world with the most deaths recorded by covid-19 and the fifth with the most cases, only 65 million people – which represents 30% of the total population – have the complete vaccination schedule, according to the reports. data from Johns Hopkins University.